Table 4 Risk for infections and additional surgery following application of the HRF, within 1 year (for superficial infection) and 2 years (for deep infection, amputation and additional surgery)
Diagnostic Categories at Time of Index | Superficial Infection During HRF Application (up to 12 months post-index) | New Deep Infection | Amputation | Additional Surgery |
|---|---|---|---|---|
Older than 17 – Acquired Deformity | 13.6% (7.6–24.4%) | 10.5% (4.7–23.4%) | 0.0% | 18.1% (8.7–37.6%) |
Older than 17 – Arthropathy | 2.8% (0.4–20.5%) | 5.2% (0.7–40.5%) | 0.0% | 3.7% (0.4–31.3%) |
Older than 17 - Deep Infection | 39.1% (25.0–61.0%) | 57.8% (33.6–99.4%) | 8.9% (3.3–23.9%) | 7.6% (2.2–26.0%) |
Older than 17 - Fracture | 21.2% (14.0–32.0%) | 6.8% (3.0–15.7%) | 2.7% (0.9–7.7%) | 6.0% (2.2–16.1%) |
Older than 17 – Nonunion No Infection | 20.4% (11.7–35.4%) | 20.1% (9.4–43.0%) | 5.0% (1.6–15.3%) | 10.3% (3.5–30.1%) |
Younger than 17 – Congenital Deformity | 18.5% (10.4–33.0%) | 3.8% (1.4–10.6%) | 0.0% | 17.4% (7.3–41.6%) |
Younger than 17 – Fracture | 21.2% (8.3–54.2%) | 7.3% (1.7–32.0%) | 0.0% | 10.2% (2.2–48.2%) |